Related references
Note: Only part of the references are listed.Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours
D. S. Boss et al.
ANNALS OF ONCOLOGY (2010)
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
N. Johnson et al.
BRITISH JOURNAL OF CANCER (2010)
IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma
Donatella Aldinucci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Classification of Therapy Resistance Based on Longitudinal Biomarker Profiles
Mareike Kohlmann et al.
BIOMETRICAL JOURNAL (2009)
Distinct Concentration-Dependent Effects of the Polo-like Kinase 1-Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis
Aidan G. Gilmartin et al.
CANCER RESEARCH (2009)
A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples
Beatriz Sanchez-Espiridion et al.
CLINICAL CANCER RESEARCH (2009)
Reliability and Reproducibility of a RNA Preamplification Method for Low-density Array Analysis From Formalin-fixed Paraffin-embedded Breast Cancer Samples
Paola Ciotti et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Multiple Gene Expression Analyses in Human Lymphoid Tissues by TaqMan Low-density Array Using Amplified RNA Isolated From Paraffin-Embedded Samples
Annunziata Gloghini et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737
Aarthi Jayanthan et al.
LEUKEMIA & LYMPHOMA (2009)
Addressing Reported Pro-Apoptotic Functions of NF-κB: Targeted Inhibition of Canonical NF-κB Enhances the Apoptotic Effects of Doxorubicin
Brian K. Bednarski et al.
PLOS ONE (2009)
Improved RNA quality and TaqMan® Pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials
Jinghuan Li et al.
BMC BIOTECHNOLOGY (2008)
Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies
Michel Noutsias et al.
BMC MOLECULAR BIOLOGY (2008)
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Alexandar Tzankov et al.
HAEMATOLOGICA (2008)
A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4
Serena Valsami et al.
HAEMATOLOGICA (2007)
Asterias:: integrated analysis of expression and aCGH data using an open-source, web-based, parallelized software suite
Ramo Diaz-Uriarte et al.
NUCLEIC ACIDS RESEARCH (2007)
Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas
Maria Bai et al.
HUMAN PATHOLOGY (2007)
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
Abel Sanchez-Aguilera et al.
BLOOD (2006)
Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control
A Sánchez-Aguilera et al.
ONCOGENE (2006)
cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3
H Dürkop et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Applications of support vector machines to cancer classification with microarray data
F Chu et al.
INTERNATIONAL JOURNAL OF NEURAL SYSTEMS (2005)
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
T Alvaro et al.
CLINICAL CANCER RESEARCH (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells
M Bai et al.
MODERN PATHOLOGY (2004)
Influence of biologic markers on the outcome of Hodgkin's lymphoma:: A study by the Spanish Hodgkin's lymphoma study group
C Montalban et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Hodgkin and Reed-Stemberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints:: analyses using tissue microarrays
JF García et al.
BLOOD (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
BCL-2 expression in Hodgkin and Reed-Stemberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens
GZ Rassidakis et al.
BLOOD (2002)
The role of cytokines in classical Hodgkin lymphoma
BF Skinnider et al.
BLOOD (2002)
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease
E Devilard et al.
ONCOGENE (2002)
Missing value estimation methods for DNA microarrays
O Troyanskaya et al.
BIOINFORMATICS (2001)
Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker
RL ten Berge et al.
LEUKEMIA (2001)
Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes:: Modulation of interferon-regulated gene expression by Rel/nuclear factor κB
RJ Grumont et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
